Actionable insights straight to your inbox

Equities logo

China’s Sinopharm Begins Phase 3 Trial of COVID-19 Vaccine Candidate in UAE

The study, the world’s first Phase III trial of an inactivated vaccine, will involve up to 15,000 volunteer patients over three to six months. 200 different nationalities are represented in the UAE.